The project aims to improve the methods for selecting sperm and embryos and increase the chance of pregnancy and live-born children.
The project aims to improve the methods for selecting sperm and embryos and increase the chance of pregnancy and live-born children.
Obesity and type 2 diabetes are associated with changes in gut microbiota and disturbed energy metabolism. Is there a crosstalk between gut bacteria and host energy metabolism?
The purpose of this PhD project is to assess whether Academic Detailing is suitable as an intervention method for pharmacy pharmacists in the subject of antibiotic treatment and resistance.
Detecting unknown adverse reactions of marketed medicines is challenging and needs improved methods to assess causality, as well as improved quality of clinical observations.
This project aims to provide new knowledge on Atlantic salmon miRNAs as regulators of immune responses to other pathogens as well as stress related to sea water transfer.
We spend much of our lives indoors where we interact with building microbiomes. We have developed methodologies to identify the microbes to which target groups are routinely exposed.
We research the role of extracellular vesicles as secreting factors from skeletal muscle, what they contain, and whether they can affect other cells.
The PhD project investigates how ocular mucin-proteins, and their glycosylation maintain a healthy tear film, while exploring their contribution to the development and progression of dry eye disease.
The project aims to define immuno-microbial signatures that can be used for non-invasive detection of colorectal cancer and pre-cancer stages.
We will develop methods for altering the naturally occurring carbohydrate surface (so-called glycocalyx) found on all the cell's surfaces in humans.
We investigate how micro- and nanoplastics affect edible plants and human health through plant uptake, packaging contamination, and sustainable solutions for safe food production.
We are developing the protein lacritin, which is found in tears, to become a medicine for dry eye disease.
We are developing nanoparticles that can act as carriers for new antibiotics to better treat biofilm-based infections.
Persistent pain and psychological distress in young adults can negatively impact participation in education and employment, leading to significant consequences.
The project seeks to develop drug formulations of novel antimicrobials, so-called bacteriocins, by applying nanotechnology and artificial intelligence.
In this PhD project we will create and validate a self-reported adherence questionnaire and use this to evaluate the effect of a digital patient intervention designed to increase adherence to medications in a specific patient group.
Our aim is to identify microbial risk profiles for disease development and severity by in-depth characterizations of the ocular microbiota of dry eye disease sufferers.
To ensure correct use of medication, information and patient-centered communication in the use of over-the-counter drugs is essential.
